Retinitis Pigmentosa (RP) is a rare genetic eye disorder that causes the retina’s cells to break down over time, leading to ...

Researchers at the National Institutes of Health (NIH) have found that reserpine, a drug no longer used for blood pressure ...

Valley parents are racing to find a treatment for their son's progressive genetic disorder that will eventually lead to him ...

Two-year data with eyeDNA Therapeutics’ gene therapy for retinitis pigmentosa (RP), an inherited ... In this group, the treatment led to improvements in best corrected visual acuity (BCVA ...

Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa. Researchers at the National Institutes of Health (NIH) have developed eye ...

Those of us committed to finding cures for diseases must remain steadfast in our dedication, regardless of the level of ...

When administered once daily to young mice with retinitis pigmentosa-like disease ... photoreceptors preserved through the eye drop treatment are healthy enough for gene therapy to work ...

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa ... low-dose MCO-010 treatment groups ...

A new type of visual prosthesis system in which nanoparticles, used in combination with a small laser device worn in a pair ...

Scientists have for the first time looked deep into the protein structure that may determine our vision - and discovered that ...